Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety, tolerability, pharmacokinetics and preliminary efficacy of AV411 in diabetic neuropathy across Phase 1 and Phase 2 st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• AV411

Snippet

Sponsor: Avigen | Conditions: Diabetic Neuropathy | Phase 1, Phase 2 | Status: COMPLETED